NFE2L2 and inflammatory bowel disease: The NRF2/KEAP1 pathway, sometimes considered to be the ‘master regulator’ of cellular antioxidant defense, is another emerging target of interest in the context of IBD because of its role in combating oxidative stress in disease progression.